NCT03583593View on ClinicalTrials.gov

Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 23, 2014

Primary Completion Date

November 12, 2017

Study Completion Date

November 30, 2017

Conditions
Diabetic Foot UlcerDiabetic FootDiabetes Mellitus, Type 2
Interventions
DIETARY_SUPPLEMENT

DIAMEL

Diamel is administered 6 capsules a day divided into three doses that are ingested before each meal.

DIETARY_SUPPLEMENT

Placebo

Placebo is administered 6 capsules a day divided into three doses that are ingested before each meal.

Trial Locations (1)

10400

National Institute of Endocrinology, Vedado

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT03583593 - Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer | Biotech Hunter | Biotech Hunter